Emerging mRNA technologies: delivery strategies and biomedical applications

Chem Soc Rev. 2022 May 23;51(10):3828-3845. doi: 10.1039/d1cs00617g.

Abstract

The great success achieved by the two highly-effective messenger RNA (mRNA) vaccines during the COVID-19 pandemic highlights the great potential of mRNA technology. Through the evolution of mRNA technology, chemistry has played an important role from mRNA modification to the synthesis of mRNA delivery platforms, which allows various applications of mRNA to be achieved both in vitro and in vivo. In this tutorial review, we provide a summary and discussion on the significant progress of emerging mRNA technologies, as well as the underlying chemical designs and principles. Various nanoparticle (NP)-based delivery strategies including protein-mRNA complex, lipid-based carriers, polymer-based carriers, and hybrid carriers for the efficient delivery of mRNA molecules are presented. Furthermore, typical mRNA delivery platforms for various biomedical applications (e.g., functional protein expression, vaccines, cancer immunotherapy, and genome editing) are highlighted. Finally, our insights into the challenges and future development towards clinical translation of these mRNA technologies are provided.

Publication types

  • Review

MeSH terms

  • COVID-19* / therapy
  • Humans
  • Immunotherapy
  • Nanoparticles* / chemistry
  • Pandemics
  • Proteins
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism

Substances

  • Proteins
  • RNA, Messenger